메뉴 건너뛰기




Volumn 27, Issue 9, 2009, Pages 745-753

Comparing three software tools for implementing markov models for health economic evaluations

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPUTER PROGRAM; COST EFFECTIVENESS ANALYSIS; HEALTH ECONOMICS; MONTE CARLO METHOD; PRIORITY JOURNAL; PROBABILITY; SMOKING CESSATION;

EID: 70349272853     PISSN: 11707690     EISSN: 11792027     Source Type: Journal    
DOI: 10.2165/11313760-000000000-00000     Document Type: Article
Times cited : (19)

References (21)
  • 2
    • 0031886073 scopus 로고    scopus 로고
    • An introduction to Markov model-ling for economic evaluation
    • Briggs A, Sculpher M. An introduction to Markov model-ling for economic evaluation. Pharmacoeconomics 1998; 13 (4): 397-409
    • (1998) Pharmacoeconomics , vol.13 , Issue.4 , pp. 397-409
    • Briggs, A.1    Sculpher, M.2
  • 3
    • 33845603069 scopus 로고    scopus 로고
    • A taxonomy of model structures for economic evaluation of health technologies
    • Dec
    • Brennan A, Chick SE, Davies R. A taxonomy of model structures for economic evaluation of health technologies. Health Econ 2006 Dec; 15: 1295-1310
    • (2006) Health Econ , vol.15 , pp. 1295-1310
    • Brennan, A.1    Chick, S.E.2    Davies, R.3
  • 4
    • 38349004700 scopus 로고    scopus 로고
    • Modelling methods for pharmacoeconomics and health technology assessment: An overview and guide
    • Stahl JE. Modelling methods for pharmacoeconomics and health technology assessment: an overview and guide. Pharmacoeconomics 2008; 26 (2): 131-148
    • (2008) Pharmacoeconomics , vol.26 , Issue.2 , pp. 131-148
    • Stahl, J.E.1
  • 6
    • 0141730309 scopus 로고    scopus 로고
    • Validation of health economic models: The example of evita
    • Sep-Oct
    • Hammerschmidt T, Goertz A, Wagenpfeil S, et al. Validation of health economic models: the example of EVITA. Value Health 2003 Sep-Oct; 6: 551-559
    • (2003) Value Health , vol.6 , pp. 551-559
    • Hammerschmidt, T.1    Goertz, A.2    Wagenpfeil, S.3
  • 7
    • 0030903704 scopus 로고    scopus 로고
    • Primer on medical decision analysis: Part 4. Analyzing the model and interpreting the results
    • Apr-Jun
    • Krahn MD, Naglie G, Naimark D, et al. Primer on medical decision analysis: part 4. Analyzing the model and interpreting the results. Med Decis Making 1997 Apr-Jun; 17: 142-151
    • (1997) Med Decis Making , vol.17 , pp. 142-151
    • Krahn, M.D.1    Naglie, G.2    Naimark, D.3
  • 8
    • 33645810425 scopus 로고    scopus 로고
    • Good practice guidelines for decision-analytic modelling in health technology assessment: A review and consolidation of quality assessment
    • Philips Z, Bojke L, Sculpher M, et al. Good practice guidelines for decision-analytic modelling in health technology assessment: a review and consolidation of quality assessment. Pharmacoeconomics 2006; 24 (4): 355-371
    • (2006) Pharmacoeconomics , vol.24 , Issue.4 , pp. 355-371
    • Philips, Z.1    Bojke, L.2    Sculpher, M.3
  • 9
    • 0034101206 scopus 로고    scopus 로고
    • Assessing quality in decision analytic cost-effectiveness models: A suggested framework and example of application
    • Sculpher M, Fenwick E, Claxton K. Assessing quality in decision analytic cost-effectiveness models: a suggested framework and example of application. Pharmacoeco-nomics 2000; 17 (5): 461-477
    • (2000) Pharmacoeco-nomics , vol.17 , Issue.5 , pp. 461-477
    • Sculpher, M.1    Fenwick, E.2    Claxton, K.3
  • 10
    • 61749095518 scopus 로고    scopus 로고
    • Comparison of Markov model and discrete-event simulation techniques for HIV
    • Simpson KN, Strassburger A, Jones WJ, et al. Comparison of Markov model and discrete-event simulation techniques for HIV. Pharmacoeconomics 2009; 27 (2): 159-165
    • (2009) Pharmacoeconomics , vol.27 , Issue.2 , pp. 159-165
    • Simpson, K.N.1    Strassburger, A.2    Jones, W.J.3
  • 11
    • 0141840679 scopus 로고    scopus 로고
    • Alternative Decision Modelling Techniques for the Evaluation of Health Care Technologies: Markov Processes Versus Discrete Event Simulation
    • Oct
    • Karnon J. Alternative decision modelling techniques for the evaluation of health care technologies: Markov processes versus discrete event simulation. Health Econ 2003 Oct; 12: 837-848
    • (2003) Health Econ , vol.12 , pp. 837-848
    • Karnon, J.1
  • 12
    • 0034086702 scopus 로고    scopus 로고
    • Handling uncertainty in cost-effectiveness models
    • Briggs AH. Handling uncertainty in cost-effectiveness models. Pharmacoeconomics 2000; 17 (5): 479-500
    • (2000) Pharmacoeconomics , vol.17 , Issue.5 , pp. 479-500
    • Briggs, A.H.1
  • 13
    • 18744388870 scopus 로고    scopus 로고
    • Pharmacoeconomic analyses using discrete event simulation
    • Caro JJ. Pharmacoeconomic analyses using discrete event simulation. Pharmacoeconomics 2005; 23 (4): 323-332
    • (2005) Pharmacoeconomics , vol.23 , Issue.4 , pp. 323-332
    • Caro, J.J.1
  • 14
    • 33846652271 scopus 로고    scopus 로고
    • Can discrete event simulation be of use in modelling major depression?
    • Dec 5[online]. Available from URL [Accessed 2009 Jul 29]
    • Le Lay A, Despiegel N, Francois C, et al. Can discrete event simulation be of use in modelling major depression? Cost Eff Resour Alloc 2006 Dec 5; 4: 19 [online]. Available from URL: http://www.resource-allocation.com/content/4/1/19 [Accessed 2009 Jul 29]
    • (2006) Cost Eff Resour Alloc , vol.4 , pp. 19
    • Le Lay, A.1    Despiegel, N.2    Francois, C.3
  • 15
    • 0032838813 scopus 로고    scopus 로고
    • On behalf of the Swiss HIV Cohort Study. Systematic validation of disease models for pharmacoeconomic evaluations
    • Aug
    • Sendi PP, Craig BA, Pfluger D, et al., on behalf of the Swiss HIV Cohort Study. Systematic validation of disease models for pharmacoeconomic evaluations. J Eval Clin Pract 1999 Aug; 5: 283-295
    • (1999) J Eval Clin Pract , vol.5 , pp. 283-295
    • Sendi, P.P.1    Craig, B.A.2    Pfluger, D.3
  • 16
    • 0003736032 scopus 로고    scopus 로고
    • GOLD: Global Initiative for Chronic Obstructive Lung Disease. Bethesda (MD National Institutes of Health, National Heart, Lung and Blood Institute
    • GOLD: Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Bethesda (MD): National Institutes of Health, National Heart, Lung and Blood Institute, 2006
    • (2006) Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
  • 17
    • 22244479358 scopus 로고    scopus 로고
    • Development of an economic model to assess the cost effectiveness of treatment interventions for chronic obstructive pulmonary disease
    • Spencer M, Briggs AH, Grossman RF, et al. Development of an economic model to assess the cost effectiveness of treatment interventions for chronic obstructive pulmonary disease. Pharmacoeconomics 2005; 23 (6): 619-637
    • (2005) Pharmacoeconomics , vol.23 , Issue.6 , pp. 619-637
    • Spencer, M.1    Briggs, A.H.2    Grossman, R.F.3
  • 19
    • 70349268066 scopus 로고    scopus 로고
    • [online] Available from URL [Accessed 2009 Jul 29]
    • Rockwell Automation. Arena basic edition [online]. Available from URL: http://www.arenasimulation.com/products/basic-edition.asp [Accessed 2009 Jul 29]
    • Rockwell Automation Arena Basic Edition
  • 20
    • 70349286517 scopus 로고    scopus 로고
    • [online] Available from URL [Accessed Jul 29]
    • TreeAge software [online]. Available from URL: http://server. treeage.com/treeagepro/purchase/index.asp [Accessed 2009 Jul 29]
    • (2009)
  • 21
    • 70349281970 scopus 로고    scopus 로고
    • [online]. Available from URL [ Accessed 2009 Jul 29]
    • Microsoft Office Excel 2007 [online]. Available from URL: http://store.microsoft.com/microsoft/Office-Excel-2007/product/C8CAFA6A [Accessed 2009 Jul 29]


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.